Citigroup Lowers GE HealthCare Technologies (NASDAQ:GEHC) Price Target to $84.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price dropped by stock analysts at Citigroup from $88.00 to $84.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Citigroup’s price objective suggests a potential upside of 19.44% from the company’s current price.

Several other equities analysts have also recently commented on GEHC. Morgan Stanley upped their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their target price for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $70.33 on Wednesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $89.77. The company has a fifty day moving average price of $81.02 and a 200 day moving average price of $78.51. The stock has a market cap of $32.05 billion, a P/E ratio of 15.42, a PEG ratio of 1.60 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the firm posted $1.45 EPS. The business’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts anticipate that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in GEHC. Nalls Sherbakoff Group LLC acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $52,000. Corient Private Wealth LLC increased its position in shares of GE HealthCare Technologies by 18.7% during the 4th quarter. Corient Private Wealth LLC now owns 65,023 shares of the company’s stock worth $5,309,000 after purchasing an additional 10,226 shares in the last quarter. Auto Owners Insurance Co lifted its holdings in GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares during the last quarter. Reflection Asset Management bought a new position in GE HealthCare Technologies during the 4th quarter valued at about $36,000. Finally, Strategic Investment Solutions Inc. IL boosted its position in GE HealthCare Technologies by 404.0% in the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,255 shares of the company’s stock valued at $103,000 after buying an additional 1,006 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.